Rieflin William Jl
Lyell Immunopharma, Inc. · Director
Rieflin William Jl is listed in filings as Director at Lyell Immunopharma, Inc.. This profile follows SEC Form 4 activity through May 19, 2025, including 2 public disclosures. Recent filings connect the profile to Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Jun 17, 2024 to May 19, 2025. Reported amounts are shown as $52.2K to $306.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||